Shanshan Deng

Program: Pharmaceutical Sciences

Graduated: Fall 2020

Research title: VERU-111 as an Oral Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer and Evaluation of Novel Tubulin Inhibitors for Cancer Therapy

Advisor: Wei Li

Faculty committee status: Approved

Committee member Program Affiliation
Duane D Miller Pharmaceutical Sciences Pharmaceutical Sciences
Tiffany N Seagroves Biomedical Sciences Pathology
Murali M Yallapu Pharmaceutical Sciences Pharmaceutical Sciences
Junming Yue Biomedical Sciences Pathology